Clinical Trials

236 enrolled

Prostatic Neoplasms

NCT03768570 2026-02-02

Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

82 enrolled

Urinary Bladder Neoplasms

NCT06470243 2026-01-22

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

528 enrolled

Prostatic Neoplasms

NCT06592924 2026-01-14

TRIPLE-SWITCH

830 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06235697 2026-01-13

ASCENDE-SBRT

710 enrolled

Prostatic Neoplasms

NCT01809691 2025-12-31

S1216

Phase 3 Completed

1,313 enrolled 22 charts

Prostatic Neoplasms

NCT00309985 2025-12-11

CHAARTED

Phase 3 Completed

790 enrolled 11 charts

Phase NA Active not recruiting

Metastatic Hormone-sensitive Prostate Cancer

NCT03784755 2025-11-20

PLATON

409 enrolled

Prostate Cancer Metastatic

NCT04663997 2025-11-06

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

200 enrolled

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms

NCT06520449 2025-09-25

NTA-476

10 enrolled

Prostatic Neoplasms

NCT02194842 2025-09-19

PEACE III

446 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT02972060 2025-09-19

ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer

61 enrolled

Prostatic Neoplasms

NCT05974774 2025-09-19

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

1,600 enrolled

Prostatic Neoplasms

NCT01120249 2025-09-16

S0931

Phase 3 Completed

1,545 enrolled 15 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04510597 2025-09-09

PROBE

364 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT01230866 2025-09-04

Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer

150 enrolled

Prostatic Neoplasms

NCT01492972 2025-09-04

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

192 enrolled

Prostatic Neoplasms

NCT03385655 2025-08-21

Prostate Cancer Biomarker Enrichment and Treatment Selection

200 enrolled

Prostatic Neoplasms

NCT00945009 2025-05-31

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

249 enrolled 14 charts

Beckwith-Wiedemann Syndrome, Wilms Tumor

NCT02788773 2025-05-15

Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer

52 enrolled 12 charts

Prostatic Neoplasms

NCT03757949 2025-05-15

Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery

203 enrolled 9 charts

Urinary Bladder Neoplasms

NCT00567580 2025-05-09

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

1,792 enrolled 27 charts

Phase NA Active not recruiting

Prostatic Neoplasms

NCT02960087 2025-04-15

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

334 enrolled

Prostatic Neoplasms

NCT03091660 2025-04-02

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

1,000 enrolled

Stage 0 Bladder Urothelial Carcinoma

NCT01309672 2025-02-26

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

41 enrolled 18 charts

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06783348 2025-01-23

RENALUT

48 enrolled

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

NCT04871529 2024-12-30

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Phase 2 Terminated

6 enrolled 12 charts

Urinary Bladder Neoplasms

NCT01224665 2024-11-29

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Phase NA Completed

658 enrolled 19 charts

Urinary Bladder Neoplasms

NCT02799706 2024-11-05

PEGASUS

885 enrolled

Prostatic Neoplasms

NCT03869762 2024-09-25

DICE

Phase 2 Terminated

7 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00981656 2024-09-19

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

37 enrolled 19 charts

Urinary Bladder Neoplasms

NCT02177695 2024-09-19

COXEN

237 enrolled 20 charts